Relaxing incisions reduce postop astigmatism

Article

Relaxing incisions are a safe and effective method for reducing postoperative astigmatism and help improve visual acuity (VA), according to a study published in the March issue of the Journal of Refractive Surgery.

Relaxing incisions are a safe and effective method for reducing postoperative astigmatism and help improve visual acuity (VA), according to a study published in the March issue of the Journal of Refractive Surgery.

Margareta Claesson, MD and John Armitage, PhD, from the Sahlgrenska University Hospital, Sweden and the University of Bristol, UK, respectively, conducted a study to determine the impact of relaxing incisions for correcting postoperative astigmatism following penetrating keratoplasty.

Data was collected through the Swedish Corneal Transplant Register and, of the 1,161 grafts with complete two-year follow-up, 131 underwent relaxing incisions. Stepwise multiple regression was used to determine the factors that influenced the extent of astigmatism. The change in astigmatism brought about by relaxing incisions was evaluated by subtraction and vector analysis.

In patients who underwent relaxing incisions, astigmatism was reduced from 8.40 D to 3.80 D. The mean difference by subtraction was 4.50 D and vector analysis showed the overall reduction of astigmatism induced by surgery to be 7.90 D. Compared with grafts with no refractive surgery, a trend was seen that suggested corrected VA was improved following relaxing incisions.

It was concluded that relaxing incisions are safe and effective as a method of reducing postoperative astigmatism and may even help improve VA in some cases.

Recent Videos
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
Brent Kramer, MD, of Vance Thompson Vision speaks at the 2024 AAO meeting
© 2025 MJH Life Sciences

All rights reserved.